Skip to content

🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

About
Trials
Programs
Resources
Contact
Free Sessions

Our coverage on the latest scoop

News and Media Releases

Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application, Paving the Way for the Largest Psilocybin Trial to Date

This trial will assess psilocybin efficacy in frontline healthcare professionals...

ATMA Journey Centers observes positive outcomes from a Phase I clinical trial of psilocybin in healthy participants

Fourteen healthy subjects completed an experiential session after receiving 25...

Catalyst Summit 2022 Canada’s conference on psychedelic medicine on May 20-22, 2022

ATMA Sponsors Catalyst Summit 2022 on Psychedelic Medicine

ATMA to Sponsor Catalyst Summit 2022, May 20-22

ATMA Submits Phase II Clinical Trial Application, Assessing Psilocybin Efficacy in Healthcare Professionals Suffering From COVID-19-Related Mental Wellness Challenges.

CALGARY, AB, May 10, 2022 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), an Alberta-based company...

Filament Health and ATMA Journey Centers Announce Licensing Agreement

ATMA will use Filament’s proprietary botanical drug candidate for clinical...

Health Canada Provides a No-Objection Letter to Atma Journey Centers: A Clinical Trial Assessing Psilocybin Safety and Exploring Psychological Outcome in Licensed Medical Practitioners

CALGARY, AB, Jan. 7, 2022 /CNW/ – ATMA Journey Centers...

Our Gratitude and Reflection for 2021

Hello,’Tis the season to sit back and reflect on the...

A means to incorporating Psychedelic Therapy

ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice

The program will support greater accessibility and affordability for clients...

Working magic?

Mushrooms are having a moment, reports Gayle MacDonald, most notably...

Clinical Trial Application Submitted to Health Canada for Experiential, Psychedelic-Assisted Psychotherapy Training

ATMA Journey Centers have applied for Health Canada approval to...

500, 2303 4 St SW
Calgary, Alberta, Canada

Facebook Twitter Instagram Linkedin

Company

About
Careers
Clinical Trials
Contact

Programs

Introduction to Psychedelic-assisted Therapy
Psilocybin-assisted Therapy Program

Resources

Blog
News & Media Releases
Psychedelic Exposé
Oregon Services
Free Class

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of these cookies.

Do not sell my personal information.

Cookie settings ACCEPT

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT